FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Strong Response in New Moderna Covid Vaccine

Moderna says its updated Covid-19 vaccine demonstrated a strong response against the new BA.2.86 variant that is being closely watched due to having o...

latest-news-card-1
Human Drugs

FDA, Flatiron Health Real-world Data Pact

FDAs Oncology Center of Excellence and Flatiron Health renew a five-year collaboration to jointly develop and implement specific research projects to ...

Medical Devices

Breakthrough Status on Auto Glucose Device

FDA grants Admetsys a breakthrough device designation for its automated glucose control and continuous blood diagnostics system.

latest-news-card-1
Human Drugs

Tivdak Confirmatory Trial Meets Primary Endpoint

Seagen and Genmab report that their Phase 3 innovaTV 301 trial in recurrent or metastatic cervical cancer patients who received Tivdak (tisotumab vedo...

latest-news-card-1

Appeals Court Reverses Ivermectin Suit Dismissal

The 5th Circuit Court of Appeals overrules a Texas federal court and says a suit by three doctors against FDA and HHS and their top officials over mes...

latest-news-card-1
Medical Devices

Techsomed Ablation Planning Software Cleared

FDA clears a Techsomed 510(k) for its VisAble.IO software intended to assist physicians in planning liver ablation procedures and confirming ablation ...

latest-news-card-1
Human Drugs

CGMP Violations at Lex, Inc.

FDA warns Medley, FL-based Lex, Inc., about repeat CGMP violations in its production of finished drugs as a contract facility.

latest-news-card-1
Federal Register

Mycobacterial Pulmonary Disease Draft Guide

Federal Register notice: FDA publishes a draft guidance entitled Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex ...

latest-news-card-1
Federal Register

Generic Drug Warning Letter Meetings Guide

Federal Register notice: FDA posts a draft guidance entitled Post-Warning Letter Meetings Under GDUFA.

latest-news-card-1
Federal Register

35 No-Longer-Marketed NDAs Withdrawn

Federal Register notice: FDA withdraws 35 no-longer-marketed NDAs from multiple applicants.